These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 17698411)
1. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child. Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748 [TBL] [Abstract][Full Text] [Related]
3. Is combination antiviral therapy for CMV superior to monotherapy? Drew WL J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546 [TBL] [Abstract][Full Text] [Related]
4. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients. Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537 [TBL] [Abstract][Full Text] [Related]
5. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy. Gilbert C; LeBlanc MH; Boivin G Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973 [TBL] [Abstract][Full Text] [Related]
7. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay. Eckle T; Jahn G; Hamprecht K J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754 [TBL] [Abstract][Full Text] [Related]
8. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
9. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection. Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124 [TBL] [Abstract][Full Text] [Related]
10. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
11. [Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain]. Cañizares MA; Losada I; Pérez-Elías MJ; González J; Rubio R; Casado JL; Guerrero A Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):471-4. PubMed ID: 11844451 [TBL] [Abstract][Full Text] [Related]
12. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient. García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746 [TBL] [Abstract][Full Text] [Related]
13. Assay of cytomegalovirus susceptibility to ganciclovir in renal and heart transplant recipients. de Oña Navarro M; Melón S; Méndez S; Iglesias B; Palacio A; Bernardo MJ; Rodriguez-Lambert JL; Gómez E Transpl Int; 2002 Nov; 15(11):570-3. PubMed ID: 12461662 [TBL] [Abstract][Full Text] [Related]
14. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833 [TBL] [Abstract][Full Text] [Related]
15. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively. Baldanti F; Sarasini A; Silini E; Barbi M; Lazzarin A; Biron KK; Gerna G Scand J Infect Dis Suppl; 1995; 99():103-4. PubMed ID: 8668930 [TBL] [Abstract][Full Text] [Related]
16. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579 [TBL] [Abstract][Full Text] [Related]
17. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet. Drew WL; Miner RC; Marousek GI; Chou S J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820 [TBL] [Abstract][Full Text] [Related]
18. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene. Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247 [TBL] [Abstract][Full Text] [Related]
19. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact]. Reusser P; Hostettler B; Attehbofer R Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510 [TBL] [Abstract][Full Text] [Related]
20. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients. Mylonakis E; Kallas WM; Fishman JA Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]